Bionano genomics announces extensive lineup of content at association for molecular pathology (amp) annual meeting featuring ogm utility across broad range of research applications

San diego, oct. 28, 2022 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced its participation in the association for molecular pathology (amp) annual meeting and expo 2022 with a broad range of content covering optical genome mapping's (ogm) utility for research applications including prenatal and postnatal analysis, genetic disease and hematological malignancies.
BNGO Ratings Summary
BNGO Quant Ranking